CHINA HEALTH GRP HD-10 Market Cap ($581.84K)
Market Cap & Net Worth: CHINA HEALTH GRP HD-10 (VNL1)
CHINA HEALTH GRP HD-10 market cap. CHINA HEALTH GRP HD-10 (F:VNL1) has a market capitalization of $581.84K (€497.68K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31000 globally and #2724 in its home market, demonstrating a -50.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CHINA HEALTH GRP HD-10's stock price €0.00 by its total outstanding shares 995351660 (995.35 Million). Also see CHINA HEALTH GRP HD-10 (VNL1) cash flow conversion for how efficiently the company converts equity into cash flow.
CHINA HEALTH GRP HD-10 Market Cap History (2021–2026)
CHINA HEALTH GRP HD-10 market cap history from 2021 to 2026. Data shows change from $36.07 Million to $581.84K (-55.37% CAGR). Check today's stock price for CHINA HEALTH GRP HD-10 for real-time trading data and today's change.
CHINA HEALTH GRP HD-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CHINA HEALTH GRP HD-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VNL1 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.27x
CHINA HEALTH GRP HD-10's market cap is 0.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $36.07 Million | $83.60 Million | $36.33 Million | 0.43x | 0.99x |
| 2022 | $26.76 Million | $13.09 Million | -$15.83 Million | 2.04x | N/A |
| 2023 | $5.82 Million | $21.43 Million | -$58.01 Million | 0.27x | N/A |
Competitor Companies of VNL1 by Market Capitalization
Companies near CHINA HEALTH GRP HD-10 in the global market cap rankings as of November 3, 2026. Also see VNL1 total assets for a full breakdown of the balance sheet.
Key companies related to CHINA HEALTH GRP HD-10 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #142 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of CHINA HEALTH GRP HD-10 (2021–2026)
Market capitalization of CHINA HEALTH GRP HD-10 from 2021 to today. Between 2021 and today, CHINA HEALTH GRP HD-10's market cap moved from $36.07 Million to $ 581.84K, with a yearly change of -55.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €581.84K | -91.67% |
| 2025 | €6.98 Million | -50.00% |
| 2024 | €13.96 Million | +140.00% |
| 2023 | €5.82 Million | -78.26% |
| 2022 | €26.76 Million | -25.81% |
| 2021 | €36.07 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of CHINA HEALTH GRP HD-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $581.84K USD |
| MoneyControl | $581.84K USD |
| MarketWatch | $581.84K USD |
| marketcap.company | $581.84K USD |
| Reuters | $581.84K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CHINA HEALTH GRP HD-10
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People's Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research… Read more